Search by Drug Name or NDC
NDC 53002-1631-01 Reclipsen Details
Reclipsen
Reclipsen is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is .
Product Information
NDC | 53002-1631 |
---|---|
Product ID | 53002-1631_03c45581-895a-40f6-8693-104f689bbd1a |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Reclipsen |
Proprietary Name Suffix | 28 Day |
Non-Proprietary Name | Desogestrel and Ethinyl Estradiol |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | RPK Pharmaceuticals, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA075256 |
Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1631-01 (53002163101)
NDC Package Code | 53002-1631-1 |
---|---|
Billing NDC | 53002163101 |
Package | 1 BLISTER PACK in 1 PACKAGE (53002-1631-1) / 1 KIT in 1 BLISTER PACK |
Marketing Start Date | 2017-09-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |